361 related articles for article (PubMed ID: 35788622)
1. High-Dose Dexamethasone and Oxygen Support Strategies in Intensive Care Unit Patients With Severe COVID-19 Acute Hypoxemic Respiratory Failure: The COVIDICUS Randomized Clinical Trial.
Bouadma L; Mekontso-Dessap A; Burdet C; Merdji H; Poissy J; Dupuis C; Guitton C; Schwebel C; Cohen Y; Bruel C; Marzouk M; Geri G; Cerf C; Mégarbane B; Garçon P; Kipnis E; Visseaux B; Beldjoudi N; Chevret S; Timsit JF;
JAMA Intern Med; 2022 Sep; 182(9):906-916. PubMed ID: 35788622
[TBL] [Abstract][Full Text] [Related]
2. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
3. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
5. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
6. Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial.
Grieco DL; Menga LS; Cesarano M; Rosà T; Spadaro S; Bitondo MM; Montomoli J; Falò G; Tonetti T; Cutuli SL; Pintaudi G; Tanzarella ES; Piervincenzi E; Bongiovanni F; Dell'Anna AM; Delle Cese L; Berardi C; Carelli S; Bocci MG; Montini L; Bello G; Natalini D; De Pascale G; Velardo M; Volta CA; Ranieri VM; Conti G; Maggiore SM; Antonelli M;
JAMA; 2021 May; 325(17):1731-1743. PubMed ID: 33764378
[TBL] [Abstract][Full Text] [Related]
7. Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.
Brown SM; Barkauskas CE; Grund B; Sharma S; Phillips AN; Leither L; Peltan ID; Lanspa M; Gilstrap DL; Mourad A; Lane K; Beitler JR; Serra AL; Garcia I; Almasri E; Fayed M; Hubel K; Harris ES; Middleton EA; Barrios MAG; Mathews KS; Goel NN; Acquah S; Mosier J; Hypes C; Salvagio Campbell E; Khan A; Hough CL; Wilson JG; Levitt JE; Duggal A; Dugar S; Goodwin AJ; Terry C; Chen P; Torbati S; Iyer N; Sandkovsky US; Johnson NJ; Robinson BRH; Matthay MA; Aggarwal NR; Douglas IS; Casey JD; Hache-Marliere M; Georges Youssef J; Nkemdirim W; Leshnower B; Awan O; Pannu S; O'Mahony DS; Manian P; Awori Hayanga JW; Wortmann GW; Tomazini BM; Miller RF; Jensen JU; Murray DD; Bickell NA; Zatakia J; Burris S; Higgs ES; Natarajan V; Dewar RL; Schechner A; Kang N; Arenas-Pinto A; Hudson F; Ginde AA; Self WH; Rogers AJ; Oldmixon CF; Morin H; Sanchez A; Weintrob AC; Cavalcanti AB; Davis-Karim A; Engen N; Denning E; Taylor Thompson B; Gelijns AC; Kan V; Davey VJ; Lundgren JD; Babiker AG; Neaton JD; Lane HC;
Lancet Respir Med; 2023 Sep; 11(9):791-803. PubMed ID: 37348524
[TBL] [Abstract][Full Text] [Related]
8. Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical Trial.
Azoulay E; Lemiale V; Mokart D; Nseir S; Argaud L; Pène F; Kontar L; Bruneel F; Klouche K; Barbier F; Reignier J; Berrahil-Meksen L; Louis G; Constantin JM; Mayaux J; Wallet F; Kouatchet A; Peigne V; Théodose I; Perez P; Girault C; Jaber S; Oziel J; Nyunga M; Terzi N; Bouadma L; Lebert C; Lautrette A; Bigé N; Raphalen JH; Papazian L; Darmon M; Chevret S; Demoule A
JAMA; 2018 Nov; 320(20):2099-2107. PubMed ID: 30357270
[TBL] [Abstract][Full Text] [Related]
9. Effect of High-Flow Nasal Cannula Oxygen vs Standard Oxygen Therapy on Mortality in Patients With Respiratory Failure Due to COVID-19: The SOHO-COVID Randomized Clinical Trial.
Frat JP; Quenot JP; Badie J; Coudroy R; Guitton C; Ehrmann S; Gacouin A; Merdji H; Auchabie J; Daubin C; Dureau AF; Thibault L; Sedillot N; Rigaud JP; Demoule A; Fatah A; Terzi N; Simonin M; Danjou W; Carteaux G; Guesdon C; Pradel G; Besse MC; Reignier J; Beloncle F; La Combe B; Prat G; Nay MA; de Keizer J; Ragot S; Thille AW;
JAMA; 2022 Sep; 328(12):1212-1222. PubMed ID: 36166027
[TBL] [Abstract][Full Text] [Related]
10. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
11. Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19: The RECOVERY-RS Randomized Clinical Trial.
Perkins GD; Ji C; Connolly BA; Couper K; Lall R; Baillie JK; Bradley JM; Dark P; Dave C; De Soyza A; Dennis AV; Devrell A; Fairbairn S; Ghani H; Gorman EA; Green CA; Hart N; Hee SW; Kimbley Z; Madathil S; McGowan N; Messer B; Naisbitt J; Norman C; Parekh D; Parkin EM; Patel J; Regan SE; Ross C; Rostron AJ; Saim M; Simonds AK; Skilton E; Stallard N; Steiner M; Vancheeswaran R; Yeung J; McAuley DF;
JAMA; 2022 Feb; 327(6):546-558. PubMed ID: 35072713
[TBL] [Abstract][Full Text] [Related]
12. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.
Tomazini BM; Maia IS; Cavalcanti AB; Berwanger O; Rosa RG; Veiga VC; Avezum A; Lopes RD; Bueno FR; Silva MVAO; Baldassare FP; Costa ELV; Moura RAB; Honorato MO; Costa AN; Damiani LP; Lisboa T; Kawano-Dourado L; Zampieri FG; Olivato GB; Righy C; Amendola CP; Roepke RML; Freitas DHM; Forte DN; Freitas FGR; Fernandes CCF; Melro LMG; Junior GFS; Morais DC; Zung S; Machado FR; Azevedo LCP;
JAMA; 2020 Oct; 324(13):1307-1316. PubMed ID: 32876695
[TBL] [Abstract][Full Text] [Related]
13. RECOVERY- Respiratory Support: Respiratory Strategies for patients with suspected or proven COVID-19 respiratory failure; Continuous Positive Airway Pressure, High-flow Nasal Oxygen, and standard care: A structured summary of a study protocol for a randomised controlled trial.
Perkins GD; Couper K; Connolly B; Baillie JK; Bradley JM; Dark P; De Soyza A; Gorman E; Gray A; Hamilton L; Hart N; Ji C; Lall R; McGowan N; Regan S; Simonds AK; Skilton E; Stallard N; Stimpson E; Yeung J; McAuley DF
Trials; 2020 Jul; 21(1):687. PubMed ID: 32727624
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y
Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356
[TBL] [Abstract][Full Text] [Related]
15. High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial.
Maskin LP; Olarte GL; Palizas F; Velo AE; Lurbet MF; Bonelli I; Baredes ND; Rodríguez PO
Trials; 2020 Aug; 21(1):743. PubMed ID: 32843098
[TBL] [Abstract][Full Text] [Related]
16. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
17. Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial.
Hermine O; Mariette X; Tharaux PL; Resche-Rigon M; Porcher R; Ravaud P;
JAMA Intern Med; 2021 Jan; 181(1):32-40. PubMed ID: 33080017
[TBL] [Abstract][Full Text] [Related]
18. Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19: A Randomized Clinical Trial.
Ospina-Tascón GA; Calderón-Tapia LE; García AF; Zarama V; Gómez-Álvarez F; Álvarez-Saa T; Pardo-Otálvaro S; Bautista-Rincón DF; Vargas MP; Aldana-Díaz JL; Marulanda Á; Gutiérrez A; Varón J; Gómez M; Ochoa ME; Escobar E; Umaña M; Díez J; Tobón GJ; Albornoz LL; Celemín Flórez CA; Ruiz GO; Cáceres EL; Reyes LF; Damiani LP; Cavalcanti AB;
JAMA; 2021 Dec; 326(21):2161-2171. PubMed ID: 34874419
[TBL] [Abstract][Full Text] [Related]
19. Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
Dequin PF; Heming N; Meziani F; Plantefève G; Voiriot G; Badié J; François B; Aubron C; Ricard JD; Ehrmann S; Jouan Y; Guillon A; Leclerc M; Coffre C; Bourgoin H; Lengellé C; Caille-Fénérol C; Tavernier E; Zohar S; Giraudeau B; Annane D; Le Gouge A;
JAMA; 2020 Oct; 324(13):1298-1306. PubMed ID: 32876689
[TBL] [Abstract][Full Text] [Related]
20. Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial.
Dushianthan A; Clark H; Madsen J; Mogg R; Matthews L; Berry L; de la Serna JB; Batchelor J; Brealey D; Hussell T; Porter J; Djukanovic R; Feelisch M; Postle A; Grocott MPW
Trials; 2020 Dec; 21(1):1014. PubMed ID: 33302976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]